RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer comboOnce again, Big Pharma is proving out pelareorep's benefits as a combination therapy through their continued clinical trial failures as monotherapies or in combination as bispecifics.